From: Marine-derived protein kinase inhibitors for neuroinflammatory diseases
Extracts or compounds | Marine source | Therapeutic area | Possible molecular pathway |
---|---|---|---|
Methanol extracts | Marine green algae Ulva conglobata | Neuroinflammation | Inhibition of iNOS and COX-2 [77] |
Alginate-derived oligosaccharide | Various brown algae | AD | Inactivation the TLR4-NF-κB signaling pathway [78] |
Dieckol | Brown algae Ecklonia cava | Neuroinflammation | Downregulation of ERK, Akt and NADPH oxidase-mediated pathways [79] |
Floridoside | Red algae Laurencia undulata | Neuroinflammation | Inhibition of p38 and ERK [80] |
Phlorofucofuroeckol B | Brown algae Ecklonia stolonifera | Neuroinflammation | Inhibition of IκB-alpha/NF-κB and Akt/ERK/JNK pathways [81] |
Aurantiamide acetate | Marine fungus Aspergillus sp. SF-5921 | Neuroinflammation | Inhibition of NF-κB, JNK, and p38 [82] |
Citreohybridonol | Marine fungus Toxicocladosporium sp. SF-5699 | Neuroinflammation | Inhibitory effect on the NF-κB and p38 pathways [83] |
Sinuleptolide | Soft coral Sinularia kavarattiensis | Neuroinflammation | Inhibition of IL-1β, IL-6, IL-8, IL-18, and TNF-α [84] |